NCT06283875View on ClinicalTrials.gov

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2029

Conditions
Ovarian Cancer
Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Geneplus-Beijing Co. Ltd.

INDUSTRY

NCT06283875 - The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer | Biotech Hunter | Biotech Hunter